Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
TRIPLE G 5 mg triple agonist of GLP-1, GIP and glucagon receptors research reagent Triple G (retatrutide, LY3437943) is the molecule of interest Eli Lillys advanced clinical program (phase III trials, including the TRIUMPH program)
Retatrutide achieved approximately 24 to 28.7% weight loss at its highest dose over 48 to 72 weeks, compared to Mounjaro achieving approximately 20 to 22.5% at its highest dose over 72 weeks
October 5, 2022
This is good news for people who say they were not properly warned about the dangers of Ozempic and then developed serious injuries
Scale weight change tends to slow between 12 and 18 months of use
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
